Intravascular coagulation in liver disease.
作者信息
Verstraete M, Vermylen J, Collen D
出版信息
Annu Rev Med. 1974;25:447-55. doi: 10.1146/annurev.me.25.020174.002311.
Abstract
摘要
相似文献
1
Intravascular coagulation in liver disease.
Annu Rev Med. 1974;25:447-55. doi: 10.1146/annurev.me.25.020174.002311.
2
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN.
Thromb Haemost. 2008 May;99(5):980-3. doi: 10.1160/TH07-10-0637.
3
[Coagulation changes in liver diseases. Synthesis defects and disseminated intravascular coagulation].
Sangre (Barc). 1982;27(4-B):680-704.
4
Blood clotting abnormalities in liver disease.
Prog Liver Dis. 1976;5:350-62.
5
Metabolism of fibrinogen in cirrhosis of the liver.
South Med J. 1971 Oct;64(10):1690-701.
6
[The liver and plasma coagulation factors. Pathophysiology].
Thromb Diath Haemorrh Suppl. 1973;55:37-75.
7
Histological investigations of intravascular coagulation in rats with gradual occlusion of the portal vein.
Beitr Pathol. 1973 May;149(1):84-9. doi: 10.1016/s0005-8165(73)80127-1.
8
Different stimuli to disseminated intravascular coagulation in liver diseases.
Thromb Diath Haemorrh. 1972 Oct 31;28(2):325-6.
9
[Physiopathology of disseminated intravascular coagulation].
Cas Lek Cesk. 1971 Sep 10;110(37):860-3.
10
Fibrinogen metabolism in healthy dogs and in dogs with CCl 4 -induced liver damage and with portal vein occlusion.
Thromb Diath Haemorrh. 1972 Apr 30;27(2):319-36.
引用本文的文献
1
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
Intensive Care Med. 1997 Nov;23(11):1150-8. doi: 10.1007/s001340050472.
2
Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
J Mol Med (Berl). 1995 Feb;73(2):89-93. doi: 10.1007/BF00270583.
3
Antithrombin III metabolism in patients with liver disease.
J Clin Pathol. 1984 May;37(5):523-30. doi: 10.1136/jcp.37.5.523.
4
Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
Gut. 1984 Oct;25(10):1050-6. doi: 10.1136/gut.25.10.1050.
5
Immunohistochemical study on the liver in autopsy cases with disseminated intravascular coagulation (DIC) with reference to clinicopathological analysis.
Virchows Arch A Pathol Anat Histopathol. 1984;404(3):229-41. doi: 10.1007/BF00694889.
6
Carcinoma of the prostate presenting as acute disseminated intravascular coagulation.
CMAJ. 1986 Oct 1;135(7):775-6.
7
Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.
Gut. 1988 Aug;29(8):1103-8. doi: 10.1136/gut.29.8.1103.
8
Antithrombin III concentrate in the treatment of fulminant hepatic failure.
Gastroenterol Jpn. 1988 Aug;23(4):423-7. doi: 10.1007/BF02779211.
9
Fibrinolysis and the bleeding tendency in patients with hepatosplenic schistosomiasis.
J Clin Pathol. 1990 Jun;43(6):476-8. doi: 10.1136/jcp.43.6.476.
10
Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis.
Ann Rheum Dis. 1992 Mar;51(3):347-9. doi: 10.1136/ard.51.3.347.
Zotero 插件